Investing.com - Diffusion Pharma reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Diffusion Pharma announced earnings per share of $-1.3700 on revenue of $0.00. Analysts polled by Investing.com EPS of $-2.0600 on revenue of $0.00.
Diffusion Pharma 's are down 20% and is trading at $4.9900 , still down 79.63% from its 52 week high of $24.50 set on Monday, November 29, 2021.
Diffusion Pharma follows other major Healthcare sector earnings this month
Diffusion Pharma's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar